Fortrea (NASDAQ:FTRE – Get Free Report) is one of 44 publicly-traded companies in the “Medical laboratories” industry, but how does it weigh in compared to its rivals? We will compare Fortrea to similar companies based on the strength of its earnings, dividends, risk, valuation, analyst recommendations, profitability and institutional ownership. Analyst Recommendations This is a […]
Brandes Investment Partners LP bought a new stake in Fortrea Holdings Inc. (NASDAQ:FTRE – Free Report) during the fourth quarter, HoldingsChannel.com reports. The firm bought 1,692,160 shares of the company’s stock, valued at approximately $59,056,000. Other hedge funds and other institutional investors also recently made changes to their positions in the company. Boston Partners acquired […]
Brandes Investment Partners LP acquired a new position in shares of Fortrea Holdings Inc. (NASDAQ:FTRE – Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund acquired 1,692,160 shares of the company’s stock, valued at approximately $59,056,000. Brandes Investment Partners LP owned approximately 1.91% of […]
Elekta AB (publ) (OTCMKTS:EKTAY – Get Free Report) and Fortrea (NASDAQ:FTRE – Get Free Report) are both mid-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, earnings, dividends, profitability, valuation and risk. Profitability This table compares Elekta AB (publ) […]